| Market Capitalization (Millions $) |
1,725 |
| Shares
Outstanding (Millions) |
61 |
| Employees |
73 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-48 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
GH Research PLC is a biotechnology company that is focused on researching, developing, and commercializing advanced therapies for patients with significant unmet medical needs. The company is comprised of a team of experts in the fields of pharmacology, molecular biology, immunology, and genetics, all driven by a common goal to improve patient outcomes.
The company is headquartered in London, England, and it was founded in 200 Since then, GH Research has grown into a leading global biotechnology company that is committed to discovering and developing innovative treatments for patients. The company has research and development centers across the world, with a focus on developing therapies that target chronic diseases, rare diseases, and oncology.
GH Research is dedicated to solving some of the greatest challenges in drug discovery and development. The company's research areas include the development of small molecules, monoclonal antibodies, gene therapies, and immunotherapies. GH Research has several proprietary platforms that enable the identification and development of drug candidates, which includes computational biology, high-throughput screening, and bioinformatics.
The company has a strong focus on innovation and collaboration, working closely with key partners across the industry. GH Research has partnered with leading academic institutions, scientific organizations, and biopharmaceutical companies to optimize drug discovery and development, and to advance the understanding of disease biology.
The company's product pipeline includes a range of innovative therapies in various stages of development, including preclinical and clinical development. GH Research is committed to bringing these therapies to market as quickly and efficiently as possible, with the goal of improving patient outcomes and enhancing quality of life.
Overall, GH Research is a highly innovative and collaborative biotechnology company that is dedicated to solving some of the most significant challenges in drug discovery and development. With a dedicated team of experts, cutting-edge technologies, and a strong focus on developing therapies that address significant unmet medical needs, the company is poised for continued growth and success.
Company Address: Joshua Dawson House Dublin 2 0
Company Phone Number: 437 8334 Stock Exchange / Ticker: NASDAQ GHRS
|
11.66%